KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to -$3.3 billion.

  • AbbVie's Cash from Investing Activities rose 6046.51% to -$3.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.1 billion, marking a year-over-year increase of 6427.63%. This contributed to the annual value of -$20.8 billion for FY2024, which is 93633.65% down from last year.
  • According to the latest figures from Q3 2025, AbbVie's Cash from Investing Activities is -$3.3 billion, which was up 6046.51% from -$1.2 billion recorded in Q2 2025.
  • Over the past 5 years, AbbVie's Cash from Investing Activities peaked at $1.3 billion during Q3 2022, and registered a low of -$9.6 billion during Q1 2024.
  • For the 5-year period, AbbVie's Cash from Investing Activities averaged around -$1.6 billion, with its median value being -$735.0 million (2025).
  • In the last 5 years, AbbVie's Cash from Investing Activities surged by 30910.57% in 2022 and then crashed by 213739.84% in 2024.
  • Quarter analysis of 5 years shows AbbVie's Cash from Investing Activities stood at -$1.1 billion in 2021, then soared by 60.87% to -$448.0 million in 2022, then crashed by 78.57% to -$800.0 million in 2023, then tumbled by 134.25% to -$1.9 billion in 2024, then tumbled by 74.17% to -$3.3 billion in 2025.
  • Its last three reported values are -$3.3 billion in Q3 2025, -$1.2 billion for Q2 2025, and -$735.0 million during Q1 2025.